Heart failure is currently not only a major medical but also a socio-economic problem. Its prevalence is estimated at 1-2% of the population with an exponential increase in older age groups. A very important part of the treatment of heart failure is the gradual uptitration of therapy to the maximum tolerated doses. Properly conducted therapy titration requires more frequent patient contact. Thanks to the introduction of telemedicine techniques, the investigators can communicate more effectively with the patient, reach the target doses of heart failure medication faster and subsequently reduce the number of hospitalizations due to worsening of heart failure.

This study investigates effect of advanced telemonitoring of patients with heart failure in home environment.

Inclusion Criteria:

• LVEF ≤ 40%
• exclusion of obstructive coronary artery disease
• NTproBNP ≥ 125pg/ml
• ≥ 60 years of age
• Informed written and verbal consent
• Able to participate in study activities

Exclusion Criteria:

• LVEF ≥ 40%
• Ischaemic ethiology of cardiomyopathy
• NTproBNP ≤ 125pg/ml
• Severe psychological disturbances
• Absence of collaboration (informed consent)
• BP ≤ 110mmHg without hypertensive medication

Patients with newly diagnosed heart failure with reduced ejection fraction due to non-ischemic cardiomyopathy.